Kymera Therapeutics, Inc. (KYMR)
83.10
+4.87
(+6.23%)
USD |
NASDAQ |
Jun 11, 16:00
83.10
0.00 (0.00%)
After-Hours: 19:32
Kymera Therapeutics Total Assets (Quarterly) : 1.669B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.669B |
| December 31, 2025 | 1.743B |
| September 30, 2025 | 1.102B |
| June 30, 2025 | 1.131B |
| March 31, 2025 | 918.31M |
| December 31, 2024 | 978.04M |
| September 30, 2024 | 1.035B |
| June 30, 2024 | 826.02M |
| March 31, 2024 | 868.25M |
| December 31, 2023 | 575.76M |
| September 30, 2023 | 552.38M |
| June 30, 2023 | 581.94M |
| March 31, 2023 | 613.90M |
| Date | Value |
|---|---|
| December 31, 2022 | 603.13M |
| September 30, 2022 | 638.47M |
| June 30, 2022 | 523.42M |
| March 31, 2022 | 563.06M |
| December 31, 2021 | 605.90M |
| September 30, 2021 | 642.45M |
| June 30, 2021 | 434.39M |
| March 31, 2021 | 464.55M |
| December 31, 2020 | 487.18M |
| September 30, 2020 | 507.36M |
| June 30, 2020 | 181.11M |
| March 31, 2020 | |
| December 31, 2019 | 116.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.254B |
| Erasca, Inc. | 461.23M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Sarepta Therapeutics, Inc. | 3.179B |
| Vir Biotechnology, Inc. | 1.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 129.38M |
| Shareholders Equity (Quarterly) | 1.540B |
| Debt to Equity Ratio | 0.0523 |
| Current Ratio | 10.81 |
| Net Debt Paydown Yield | 0.02% |